biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sniper007on May 16, 2014 2:52pm

157 Views

Post# 22571304

RE:A Response to DrJ about Patel, the Bakers and Synageva

*$%^, great post Jdstox. Thank you. And thank you for all you've done for this forum. We're so fortunate to have you post your thoughts and research here - so fortunate! You rock.

"One deal, with the right partner, and this will walk away from the smallness we've witnessed so far." I was just thinking something similar this morning but I was thinking it doesn't necessarily have to be the "right partner" but rather ONE MORE significant player for a significant sp move. The "right partner" though, could take us to Mars!

Give us GEVA! Go BTI.

Sniper

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!